NLS Pharmaceutics AG (NLSP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NLS Pharmaceutics AG

    NASDAQ: NLSP · Real-Time Price · USD
    2.00
    -0.12 (-5.66%)
    At close: Oct 03, 2025, 3:59 PM
    1.98
    -0.75%
    After-hours: Oct 03, 2025, 07:41 PM EDT

    NLS Pharmaceutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 3.32K 11.41K 11.41K 11.41K 11.41K 10.73K 10.05K 5.02K
    Gross Profit
    		 -3.32K -11.41K -11.41K -11.41K -11.41K -10.73K -10.05K -5.02K
    Operating Income
    		 -4.38M -6.31M -11.81M -14.34M -15.48M -16.01M -11.86M -5.76M
    Interest Income
    		 n/a n/a 0.13 91.82 100.87 9.18 68.13 213.50
    Pretax Income
    		 -1.98M -6.6M -12.17M -15.47M -16.5M -15.98M -11.95M -6.23M
    Net Income
    		 -1.98M -2.04M -7.62M -15.47M -16.5M -15.98M -11.95M -6.23M
    Selling & General & Admin
    		 3.21M 1.78M 3.16M 6.52M 6.49M 6.39M 5.93M 3.89M
    Research & Development
    		 422.05K 272.87K 4.39M 7.82M 8.98M 9.6M 5.92M 1.86M
    Other Expenses
    		 743.84K 4.25M 4.25M n/a n/a n/a n/a n/a
    Operating Expenses
    		 4.37M 6.31M 11.8M 14.33M 15.47M 16M 11.85M 5.76M
    Interest Expense
    		 150.02K 232.01K 145.15K 91.81K 100.87K 9.18K 68.13K 213.5K
    Selling & Marketing Expenses
    		 1.77M 1.77M 3.16M 6.51M 6.49M 6.39M 5.93M 3.89M
    Cost & Expenses
    		 4.38M 6.31M 11.81M 14.34M 15.48M 16.01M 11.86M 5.76M
    Income Tax Expense
    		 n/a n/a -4 -8 -8 -3.5 -1.5 -1.5
    Shares Outstanding (Basic)
    		 55K 41.95M 32.43M 38.18M 26.68M 15.89M 14.75M 11.07M
    Shares Outstanding (Diluted)
    		 2.04M 41.95M 32.43M 38.18M 26.68M 15.89M 14.75M 11.07M
    EPS (Basic)
    		 -2.63 -0.14 -0.34 -0.49 -0.83 -1.04 -0.92 -0.76
    EPS (Diluted)
    		 -0.99 -0.14 -0.34 -0.49 -0.83 -1.04 -0.92 -0.76
    EBITDA
    		 -3.53M -6.35M -11.95M -14.33M -15.47M -16.02M -11.88M -6.02M
    EBIT
    		 -3.53M -6.21M -11.81M -14.34M -15.48M -16.01M -11.86M -6.03M
    Depreciation & Amortization
    		 3.32K 5.71K 5.71K 11.41K 11.41K 10.73K 10.05K 6.24K

    Add to Watchlist